Fu L W, Longhurst J C
Division of Cardiovascular Medicine, Departments of Internal Medicine and Human Physiology, University of California, Davis, California 95616, USA.
Am J Physiol. 1998 Dec;275(6):H2025-35. doi: 10.1152/ajpheart.1998.275.6.H2025.
Phenylbiguanide (PBG), a 5-HT3 (serotonin) receptor agonist, has been used in many studies as a "selective" agonist to elicit reflex bradycardia and hypotension through activation of cardiac and pulmonary vagal afferents. Because we have shown that endogenous 5-HT stimulates ischemically sensitive abdominal sympathetic afferents through 5-HT3 receptors, we investigated the possibility that left ventricular (LV) and intra-arterial administration of PBG may evoke a competing reflex response by increasing the activity of sympathetic visceral afferents in anesthetized cats. Mean arterial pressure (MAP) and heart rate (HR) were monitored. When both vagal and sympathetic afferents were intact, PBG (40 microgram/kg, injected into the LV) significantly decreased MAP and HR in 8 of 10 cats but increased MAP in the remaining 2 cats. After bilateral cervical vagotomy, LV PBG significantly increased MAP. PBG (40 microgram/kg ia) significantly increased MAP and HR, whereas intravenous PBG significantly decreased MAP and HR (n = 10 cats). Furthermore, the pressor response to PBG (40 microgram /kg ia) was reduced by 68% (P < 0.05; n = 4 cats) by celiac and mesenteric ganglionectomies. In studies of single-unit abdominal sympathetic afferents, intra-arterial but not intravenous PBG (40 microgram/kg) significantly increased activity of 10 ischemically sensitive afferents but not ischemically insensitive afferents. Blockade of 5-HT3 receptors with tropisetron (200 microgram/kg iv) eliminated the response of the afferents and the pressor response to PBG. These data indicate that PBG administered into the LV usually, but not always, evokes a depressor response that is converted to a pressor response following cervical vagotomy. Also, intra-arterial PBG induces a pressor response by stimulating 5-HT3 receptors largely associated with ischemically sensitive abdominal sympathetic afferents.
苯乙双胍(PBG)是一种5-羟色胺3(5-羟色胺)受体激动剂,在许多研究中被用作“选择性”激动剂,通过激活心脏和肺迷走神经传入纤维来引发反射性心动过缓和低血压。因为我们已经表明内源性5-羟色胺通过5-羟色胺3受体刺激对缺血敏感的腹部交感神经传入纤维,所以我们研究了在麻醉猫中左心室(LV)和动脉内给予PBG是否可能通过增加交感神经内脏传入纤维的活动而引发竞争性反射反应的可能性。监测平均动脉压(MAP)和心率(HR)。当迷走神经和交感神经传入纤维均完整时,PBG(40微克/千克,注入左心室)在10只猫中的8只中显著降低MAP和HR,但在其余2只猫中升高MAP。双侧颈迷走神经切断术后,左心室给予PBG显著升高MAP。PBG(40微克/千克动脉内注射)显著升高MAP和HR,而静脉注射PBG显著降低MAP和HR(n = 10只猫)。此外,腹腔和肠系膜神经节切除术使对PBG(40微克/千克动脉内注射)的升压反应降低了68%(P < 0.05;n = 4只猫)。在对单个单位腹部交感神经传入纤维的研究中,动脉内而非静脉内给予PBG(40微克/千克)显著增加了10条对缺血敏感的传入纤维的活动,但未增加对缺血不敏感的传入纤维的活动。用托烷司琼(200微克/千克静脉注射)阻断5-羟色胺3受体消除了传入纤维的反应以及对PBG的升压反应。这些数据表明,注入左心室的PBG通常但并非总是引发降压反应,颈迷走神经切断术后该反应转变为升压反应。此外,动脉内给予PBG通过刺激主要与对缺血敏感的腹部交感神经传入纤维相关的5-羟色胺3受体诱导升压反应。